A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL

NCT02055820 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

267

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG: Venetoclax
DRUG: Cyclophosphamide
DRUG: Obinutuzumab
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]